Long Interspersed Element-1 Expression in Ovarian Cancers and Precancerous Lesions Including Serous Tubal Intraepithelial Carcinomas and p53 Signatures

被引：0

作者：

Asaka, Shiho ^{[1
]}

Pisanic, Thomas ^{[2
]}

Wang, Jeff ^{[3
]}

Burns, Kathleen ^{[1
]}

Wang, Tian-Li ^{[4
]}

Shih, le-Ming ^{[5
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[2] Johns Hopkins Univ, Baltimore, MD USA

[3] Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA

[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA

来源：

MODERN PATHOLOGY | 2019年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

1001

引用

页数：1

共 50 条

[21] p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers [J].

Devor, Eric J. ;

Gonzalez-Bosquet, Jesus ;

Warrier, Akshaya ;

Reyes, Henry D. ;

Ibik, Nonye V. ;

Schickling, Brandon M. ;

Newtson, Andreea ;

Goodheart, Michael J. ;

Leslie, Kimberly K. .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (05) :1721-1728

[22] p53 aggregation promotes transformation from non-malignant lesions to high-grade serous ovarian carcinomas [J].

Sartini, Sara ;

Omholt, Lexi ;

Moatamed, Neda A. ;

Soragni, Alice .

CANCER RESEARCH, 2024, 84 (06)

[23] Correlation of long interspersed element-1 open reading frame 1 and c-Met proto-oncogene protein expression in ovarian cancer [J].

Ko, Eun-Ji ;

Oh, Young Lim ;

Kim, Heung Yeol ;

Eo, Wan Kyu ;

Kim, Hongbae ;

Ock, Mee Sun ;

Kim, Heui-Soo ;

Kim, Ki Hyung ;

Cha, Hee-Jae .

GENES & GENOMICS, 2019, 41 (11) :1293-1299

[24] Correlation of long interspersed element-1 open reading frame 1 and c-Met proto-oncogene protein expression in ovarian cancer [J].

Eun-Ji Ko ;

Young Lim Oh ;

Heung Yeol Kim ;

Wan Kyu Eo ;

Hongbae Kim ;

Mee Sun Ock ;

Heui-Soo Kim ;

Ki Hyung Kim ;

Hee-Jae Cha .

Genes & Genomics, 2019, 41 :1293-1299

[25] COMPARISON OF P53 AND MIB-1 EXPRESSION IN BENIGN AND BORDERLINE AREAS OF OVARIAN SEROUS TUMORS [J].

MARCELLI, A ;

DEMOPOULOS, R ;

GOSWAMI, S ;

MITTAL, K .

LABORATORY INVESTIGATION, 1995, 72 (01) :A93-A93

[26] Comparison of p53 and MIB1 expression in benign and borderline areas of ovarian serous tumors [J].

Marcelli, AR ;

Demopoulos, RI ;

Goswami, S ;

Mittal, KR .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1996, 15 (01) :39-44

[27] The miR-34 Family (a, b, and c) and p53 Expression in ER-Positive Breast and Ovarian Serous Cancers [J].

Lee, J. H. ;

Kim, S. ;

Kim, I. .

MODERN PATHOLOGY, 2014, 27 :292A-292A

[28] The miR-34 Family (a, b, and c) and p53 Expression in ER-Positive Breast and Ovarian Serous Cancers [J].

Lee, J. H. ;

Kim, S. ;

Kim, I. .

LABORATORY INVESTIGATION, 2014, 94 :292A-292A

[29] P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas [J].

Sundov, Dinka ;

Caric, Ana ;

Mrklic, Ivana ;

Gugic, Dijana ;

Capkun, Vesna ;

Hofman, Irena Drmic ;

Mise, Branka Petric ;

Tomic, Snjezana .

DIAGNOSTIC PATHOLOGY, 2013, 8

[30] THE RATIO OF Δ133P53 EXPRESSION TO FULL-LENGTH P53 INDICATES IMPROVED OVERALL SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCERS [J].

Bischof, K. ;

Knappskog, S. ;

Leirvaag, B. ;

Gjertsen, B. T. ;

Salvesen, H. B. ;

Bjorge, L. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) :1299-1299

← 1 2 3 4 5 →